title: Pharmacogenomic testing and the prospect of individualized treatment.
abstract: Pharmacogenomics offers the hope of greater individualization of treatment. Therapies that exemplify the promise of pharmacogenomics include anticoagulation with warfarin and the use of antiplatelet medications (eg, clopidogrel) for secondary prevention after acute coronary syndrome. Good evidence of clinical utility must be obtained before pharmacogenomic testing is widely implemented.
authors: Department of Medicine, University of North Carolina School of Medicine; Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina Eshelman School Of Pharmacy; and Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, 5034 Old Clinic Bldg., CB 7110, Chapel Hill, NC 27599, USA. daniel_jonas@med.unc.edu.
authors: Daniel E
authors: DE
authors: Jonas
authors: Roberta
authors: R
authors: Wines
mesh_terms: D006801:Humans; D010597:Pharmacogenetics; D057285:Precision Medicine